Neil E. Kay
Impact in
- Genetics top 0.01%
- Chronic Lymphocytic Leukemia Research
- Pathology and Forensic Medicine top 0.02%
- Lymphoma Diagnosis and Treatment
Papers in
- Genetics 407
- Chronic Lymphocytic Leukemia Research 403
-
- Lymphoma Diagnosis and Treatment 194
- Co-authors
- Tait D. Shanafelt (215 shared papers)Diane F. Jelinek (95 shared papers)Timothy G. Call (165 shared papers)Clive S. Zent (97 shared papers)Susan L. Slager (131 shared papers)Michael R. Grever (10 shared papers)Nancy D. Bone (37 shared papers)J M Bennett (1 shared paper)
- Journals
- Blood (170 papers)British Journal of Haematology (31 papers)Journal of Clinical Oncology (30 papers)Leukemia Research (18 papers)Leukemia (17 papers)
- Partner nations
- United StatesUnited KingdomItaly
In The Last Decade
Neil E. Kay
475 papers receiving 17.0k citations
Neil E. Kay's Hit Papers
Peers
Comparison fields: 5 of 155
- Genetics 10.9k
- Pathology and Forensic Medicine 6.9k
- Immunology 5.8k
- Hematology 2.9k
- Oncology 2.6k
Countries citing papers authored by Neil E. Kay
This map shows the geographic impact of Neil E. Kay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neil E. Kay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neil E. Kay more than expected).
Fields of papers citing papers by Neil E. Kay
This network shows the impact of papers produced by Neil E. Kay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neil E. Kay. The network helps show where Neil E. Kay may publish in the future.
Co-authors
The 25 scholars most cited alongside Neil E. Kay, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 496 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment Hit paper breakdown → | 1996 | 1470 |
| 2 | ZAP-70 Compared with Immunoglobulin Heavy-Chain Gene Mutation Status as a Predictor of Disease Progression in Chronic Lymphocytic Leukemia Hit paper breakdown → | 2004 | 657 |
| 3 | 1988 | 326 | |
| 4 | 2005 | 264 | |
| 5 | 2009 | 256 | |
| 6 | 2008 | 240 | |
| 7 | 2002 | 233 | |
| 8 | 2006 | 220 | |
| 9 | 2002 | 191 | |
| 10 | 2009 | 190 | |
| 11 | 2006 | 184 | |
| 12 | 2003 | 183 | |
| 13 | 2014 | 182 | |
| 14 | 2004 | 176 | |
| 15 | 2002 | 173 | |
| 16 | 2003 | 167 | |
| 17 | 2007 | 165 | |
| 18 | 2001 | 164 | |
| 19 | 2013 | 160 | |
| 20 | 1984 | 159 |
About Neil E. Kay
Neil E. Kay is a scholar working on Genetics, Pathology and Forensic Medicine, Immunology, Molecular Biology and Hematology, having authored 496 papers that have together received 17.4k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (403 papers), Lymphoma Diagnosis and Treatment (194 papers), Immunodeficiency and Autoimmune Disorders (110 papers), Monoclonal and Polyclonal Antibodies Research (39 papers), Advanced Breast Cancer Therapies (39 papers), Acute Lymphoblastic Leukemia research (34 papers), Glycosylation and Glycoproteins Research (32 papers) and Chronic Myeloid Leukemia Treatments (32 papers). The work is most often cited by research in Genetics (10.9k citations), Pathology and Forensic Medicine (6.9k citations), Immunology (5.8k citations), Hematology (2.9k citations) and Oncology (2.6k citations). Neil E. Kay has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include Tait D. Shanafelt, Diane F. Jelinek, Timothy G. Call, Clive S. Zent, Susan L. Slager, Michael R. Grever, Nancy D. Bone, J M Bennett, KR Rai and Stephen J. O’Brien. Their work appears in journals such as Blood, British Journal of Haematology, Journal of Clinical Oncology, Leukemia Research and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.